AC Immune raises CHF 20 million and initiates world's first anti-pTau vaccine trial for Alzheimer's disease

09.January 2014 08:00 CET

English
Franšais
Deutsch

  • CHF 20 million round D secured from existing investors
  • World's first Alzheimer's vaccine trial against phospho-Tau hallmark